Celularity Change In Cash from 2010 to 2024

CELU Stock  USD 2.04  0.03  1.49%   
Celularity Change In Cash yearly trend continues to be comparatively stable with very little volatility. Change In Cash is likely to outpace its year average in 2024. From the period from 2010 to 2024, Celularity Change In Cash quarterly data regression had mean square error of 143.2 T and mean deviation of  6,654,951. View All Fundamentals
 
Change In Cash  
First Reported
2019-03-31
Previous Quarter
-4.9 M
Current Value
-1.4 M
Quarterly Volatility
31.8 M
 
Covid
Check Celularity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Celularity's main balance sheet or income statement drivers, such as Interest Expense of 2.8 M, Ebit of 17.2 M or Net Income Applicable To Common Shares of 17.1 M, as well as many indicators such as Price To Sales Ratio of 1.84, Dividend Yield of 0.0 or PTB Ratio of 1.13. Celularity financial statements analysis is a perfect complement when working with Celularity Valuation or Volatility modules.
  
Check out the analysis of Celularity Correlation against competitors.
For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.

Latest Celularity's Change In Cash Growth Pattern

Below is the plot of the Change In Cash of Celularity over the last few years. It is Celularity's Change In Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Celularity's overall financial position and show how it may be relating to other accounts over time.
Change In Cash10 Years Trend
Very volatile
   Change In Cash   
       Timeline  

Celularity Change In Cash Regression Statistics

Arithmetic Mean(11,506,917)
Coefficient Of Variation(100.26)
Mean Deviation6,654,951
Median(13,605,000)
Standard Deviation11,537,255
Sample Variance133.1T
Range49.3M
R-Value0.03
Mean Square Error143.2T
R-Squared0
Significance0.90
Slope90,129
Total Sum of Squares1863.5T

Celularity Change In Cash History

2024-17.7 M
2023-18.6 M
2022-23.3 M
2021-17.4 M
202026 M
2019892.3 K

About Celularity Financial Statements

Celularity shareholders use historical fundamental indicators, such as Change In Cash, to determine how well the company is positioned to perform in the future. Although Celularity investors may analyze each financial statement separately, they are all interrelated. The changes in Celularity's assets and liabilities, for example, are also reflected in the revenues and expenses on on Celularity's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Change In Cash-18.6 M-17.7 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Celularity Stock Analysis

When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.